speb/financial-data huggingface dataset:
Financial ratios for SITM — quarterly report dated 2025-06-30
Total revenue: 69494000
Gross profit: 36052000
Operating income: -22739000
Net income: -20179000
Capital expenditures: 18235000
Operating cash flow: 15342000
Depreciation & amortization: 9777000
Net tangible assets: 857639000
Owner earnings: -28637000
Return on net tangible assets (%): -3.3390505795561998
Buffett classification: The Gruesome
Stock price: 213.08
Shares outstanding: 29955519
Book value: 1100681000
P/B ratio: 5.799066204031868
Market cap (USD): 6382921988.52
Debt to equity: 0.0047652317065525794
Current ratio: 8.544577932342712
Quick ratio: 7.76231611835376
COGS to revenue (%): 48.12214004086684
R&D to revenue (%): 43.97933634558379
SG&A to revenue (%): 40.61933404322675
Free cash flow (dilution-adjusted): -29251000
Buyback yield (%): 0
Retained earnings: -226057000
Inventory turnover: 0.39752276347383686
Receivables turnover: 2.586689496017271
Capitalized R&D asset: 50680420
ROCI (R&D-adjusted, %): -1.0205885011855098
Rosenberg metric: 0.19036834743222542
FCF margin (%): -42.091403574409306
Revenue growth (%): 15.220346851477268
Rule of 40 score: -26.87105672293204
Financial ratios for SITM — quarterly report dated 2025-09-30
Total revenue: 83567000
Gross profit: 44717000
Operating income: -15895000
Net income: -8014000
Capital expenditures: 5094000
Operating cash flow: 31402000
Depreciation & amortization: 9944000
Net tangible assets: 864168000
Owner earnings: -3164000
Return on net tangible assets (%): -0.3661325112709566
Buffett classification: The Gruesome
Stock price: 301.31
Shares outstanding: 29955519
Book value: 1103403000
P/B ratio: 8.18005518372707
Market cap (USD): 9025897429.89
Debt to equity: 0.004019383670336224
Current ratio: 8.4207482901002
Quick ratio: 7.6370133448983095
COGS to revenue (%): 46.48964304091328
R&D to revenue (%): 35.91010805700815
SG&A to revenue (%): 36.62091495446767
Free cash flow (dilution-adjusted): -1492000
Buyback yield (%): 0
Retained earnings: -234071000
Inventory turnover: 0.4478747564644986
Receivables turnover: 3.713428723782439
Capitalized R&D asset: 60394790
ROCI (R&D-adjusted, %): -1.3112518371784658
Rosenberg metric: 0.2835127441677846
FCF margin (%): -1.7853937559084327
Revenue growth (%): 20.25066912251417
Rule of 40 score: 18.465275366605738
Financial ratios for SITM — quarterly report dated 2025-12-31
Total revenue: 113285000
Gross profit: 63881000
Operating income: 4771000
Net income: 9167000
Capital expenditures: 12389000
Operating cash flow: 25376000
Depreciation & amortization: 11431000
Net tangible assets: 921718000
Owner earnings: 8209000
Return on net tangible assets (%): 0.8906194736351032
Capex to operating income (%): 259.67302452316073
Buffett classification: The Gruesome
Stock price: 353.19
P/E ratio: 288.53468298270974
Shares outstanding: 29955519
Book value: 1156182000
P/B ratio: 9.15079957619994
Market cap (USD): 10579989755.61
Debt to equity: 0.003122345789849695
Current ratio: 11.300267841199929
Quick ratio: 10.329408963752158
Effective tax rate (%): 4.030569514237857
COGS to revenue (%): 43.610363243147816
R&D to revenue (%): 24.976828353268303
SG&A to revenue (%): 27.20130643951097
Free cash flow (dilution-adjusted): -11645000
Buyback yield (%): 0
Retained earnings: -224904000
Inventory turnover: 0.6057603884399868
Receivables turnover: 2.515208703374778
Capitalized R&D asset: 58486820
ROCI (R&D-adjusted, %): 0.27132986981844465
Rosenberg metric: 0.6386084174747576
FCF margin (%): -10.279383854879287
Revenue growth (%): 35.561884475929496
Rule of 40 score: 25.28250062105021
Financial ratios for SITM — annual report dated 2025-12-31
Total revenue: 326660000
Gross profit: 174986000
Operating income: -60411000
Net income: -42903000
Capital expenditures: 52028000
Operating cash flow: 87154000
Depreciation & amortization: 40189000
Net tangible assets: 921718000
Owner earnings: -54742000
Return on net tangible assets (%): -5.939126717716264
Buffett classification: The Gruesome
Stock price: 353.19
Shares outstanding: 29955519
Book value: 1156182000
P/B ratio: 9.15079957619994
Market cap (USD): 10579989755.61
Debt to equity: 0.003122345789849695
Current ratio: 11.300267841199929
Quick ratio: 10.329408963752158
COGS to revenue (%): 46.431763913549254
R&D to revenue (%): 36.396559113451296
SG&A to revenue (%): 35.66521765750321
Free cash flow (dilution-adjusted): -68842000
Buyback yield (%): 0
Retained earnings: -224904000
Inventory turnover: 1.8597300047819316
Receivables turnover: 7.252664298401421
Capitalized R&D asset: 222690220
ROCI (R&D-adjusted, %): -3.439203481673602
Rosenberg metric: 0.6596977212109868
FCF margin (%): -21.074511724729074
Revenue growth (%): 61.15680054465532
Rule of 40 score: 40.08228881992625
Financial ratios for SMR — annual report dated 2022-12-31
Total revenue: 11804000
Gross profit: 4487000
Operating income: -229995000
Net income: -25914000
Capital expenditures: 2332000
Operating cash flow: -148609000
Depreciation & amortization: 2698000
Net tangible assets: 270557000
Owner earnings: -25548000
Return on net tangible assets (%): -9.44274219480553
Buffett classification: The Gruesome
Stock price: 10.26
Shares outstanding: 346105785
Book value: 277087000
P/B ratio: 12.815633191380325
Market cap (USD): 3551045354.1
Debt to equity: 0.005658872484093444
Current ratio: 7.376481572736468
Quick ratio: 7.376481572736468
COGS to revenue (%): 61.98746187732972
R&D to revenue (%): 1081.5147407658421
SG&A to revenue (%): 468.5445611657065
Free cash flow (dilution-adjusted): -160272000
Buyback yield (%): 0.01593896848843404
Retained earnings: -182092000
Receivables turnover: 1.0540226805964819
Capitalized R&D asset: 127662000
ROCI (R&D-adjusted, %): -33.09887147621876
FCF margin (%): -1357.7770247373771
Rule of 40 score: -1357.7770247373771
Financial ratios for SMR — annual report dated 2023-12-31
Total revenue: 22810000
Gross profit: 3849000
Operating income: -275565000
Net income: -58362000
Capital expenditures: 1725000
Operating cash flow: -183254000
Depreciation & amortization: 2557000
Net tangible assets: 67420000
Owner earnings: -57530000
Return on net tangible assets (%): -85.33076238504894
Buffett classification: The Gruesome
Stock price: 3.29
Shares outstanding: 346105785
Book value: 129338000
P/B ratio: 8.803971243176793
Market cap (USD): 1138688032.65
Debt to equity: 0.011558861278201302
Current ratio: 1.7670882023371217
Quick ratio: 1.7670882023371217
COGS to revenue (%): 83.12582200789129
R&D to revenue (%): 684.1297676457694
SG&A to revenue (%): 286.733888645331
Free cash flow (dilution-adjusted): -201218000
Buyback yield (%): 0
Retained earnings: -240454000
Receivables turnover: 2.2523945887232153
Capitalized R&D asset: 241583540
ROCI (R&D-adjusted, %): -56.48943663006227
Rosenberg metric: -0.004997571712804123
FCF margin (%): -882.1481806225339
Revenue growth (%): 93.23957980345645
Rule of 40 score: -788.9086008190775
Financial ratios for SMR — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 11.58
Shares outstanding: 346105785
Market cap (USD): 4007904990.3
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SMR — quarterly report dated 2024-12-31
Capital expenditures: 151000
Buffett classification: The Gruesome
Stock price: 17.93
Shares outstanding: 346105785
Market cap (USD): 6205676725.05
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SMR — annual report dated 2024-12-31
Total revenue: 37045000
Gross profit: 32108000
Operating income: -138725000
Net income: -136623000
Capital expenditures: 151000
Operating cash flow: -108666000
Depreciation & amortization: 1842000
Net tangible assets: 592836000
Owner earnings: -134932000
Return on net tangible assets (%): -22.76042615495685
Buffett classification: The Gruesome
Stock price: 17.93
Shares outstanding: 346105785
Book value: 453120000
P/B ratio: 13.695437687698623
Market cap (USD): 6205676725.05
Debt to equity: 0
Current ratio: 5.251075544459553
Quick ratio: 5.251075544459553
COGS to revenue (%): 13.327034687542177
R&D to revenue (%): 126.37872857335672
SG&A to revenue (%): 204.8886489404778
Free cash flow (dilution-adjusted): -122352000
Buyback yield (%): 0
Retained earnings: -377077000
Receivables turnover: 1.7553544351781654
Capitalized R&D asset: 193498960
ROCI (R&D-adjusted, %): -31.164214017891727
Rosenberg metric: 0.18108939442486383
FCF margin (%): -330.2793899311648
Revenue growth (%): 62.40683910565541
Rule of 40 score: -267.8725508255094
Financial ratios for SMR — quarterly report dated 2025-03-31
Total revenue: 13375000
Gross profit: 7002000
Operating income: -35327000
Net income: -14005000
Capital expenditures: 67000
Operating cash flow: -22786000
Depreciation & amortization: 313000
Net tangible assets: 678193000
Owner earnings: -13759000
Return on net tangible assets (%): -2.0287735202221198
Buffett classification: The Gruesome
Stock price: 14.16
Shares outstanding: 346105785
Book value: 529486000
P/B ratio: 9.255878182992562
Market cap (USD): 4900857915.6
Debt to equity: 0
Current ratio: 6.22780095351609
Quick ratio: 6.22780095351609
COGS to revenue (%): 47.648598130841116
R&D to revenue (%): 68.26915887850468
SG&A to revenue (%): 173.93644859813085
Free cash flow (dilution-adjusted): -27311000
Buyback yield (%): 0
Retained earnings: -391082000
Receivables turnover: 1.0027740290898186
Capitalized R&D asset: 9131000
ROCI (R&D-adjusted, %): -5.415023837611634
FCF margin (%): -204.19439252336446
Rule of 40 score: -204.19439252336446
Financial ratios for SMR — quarterly report dated 2025-06-30
Total revenue: 8054000
Gross profit: 1781000
Operating income: -43082000
Net income: -17641000
Capital expenditures: 0
Operating cash flow: -33321000
Depreciation & amortization: 305000
Net tangible assets: 667100000
Owner earnings: -17336000
Return on net tangible assets (%): -2.598710837955329
Buffett classification: The Gruesome
Stock price: 39.56
Shares outstanding: 346105785
Book value: 498862000
P/B ratio: 27.446357619141164
Market cap (USD): 13691944854.6
Debt to equity: 0
Current ratio: 4.217829708556507
Quick ratio: 4.217829708556507
COGS to revenue (%): 77.88676434070028
R&D to revenue (%): 146.53588279115968
SG&A to revenue (%): 279.6498634219021
Free cash flow (dilution-adjusted): -38493000
Buyback yield (%): 0
Retained earnings: -408723000
Receivables turnover: 0.6294154423257268
Capitalized R&D asset: 17919770
ROCI (R&D-adjusted, %): -7.3650935046918695
Rosenberg metric: -0.5717884130982368
FCF margin (%): -477.93642910355106
Revenue growth (%): -39.78317757009346
Rule of 40 score: -517.7196066736445
Financial ratios for SMR — quarterly report dated 2025-09-30
Total revenue: 8242000
Gross profit: 2709000
Operating income: -538440000
Net income: -273319000
Capital expenditures: 0
Operating cash flow: -199799000
Depreciation & amortization: 382000
Net tangible assets: 802982000
Owner earnings: -272937000
Return on net tangible assets (%): -33.99042568824706
Buffett classification: The Gruesome
Stock price: 36
Shares outstanding: 346105785
Book value: 434816000
P/B ratio: 28.655358266485134
Market cap (USD): 12459808260
Debt to equity: 0
Current ratio: 1.615288985431795
Quick ratio: 1.615288985431795
COGS to revenue (%): 67.13176413491871
R&D to revenue (%): 134.11793254064548
SG&A to revenue (%): 6299.708808541616
Free cash flow (dilution-adjusted): -204738000
Buyback yield (%): 0
Retained earnings: -682042000
Receivables turnover: 0.5427009942714164
Capitalized R&D asset: 21974570
ROCI (R&D-adjusted, %): -117.09900210651179
Rosenberg metric: 0.07863074055244874
FCF margin (%): -2484.0815336083474
Revenue growth (%): 2.334243853985597
Rule of 40 score: -2481.7472897543616
Financial ratios for SMR — quarterly report dated 2025-12-31
Total revenue: 1942000
Gross profit: -61000
Operating income: -72722000
Net income: -50829000
Capital expenditures: 367000
Operating cash flow: -203704000
Depreciation & amortization: 270000
Net tangible assets: 1143159000
Owner earnings: -50926000
Return on net tangible assets (%): -4.454848363176076
Buffett classification: The Gruesome
Stock price: 14.17
Shares outstanding: 346105785
Book value: 1113551000
P/B ratio: 4.404215858501317
Market cap (USD): 4904318973.45
Debt to equity: 0
Current ratio: 4.298416515794309
Quick ratio: 4.298416515794309
COGS to revenue (%): 96.2409886714727
R&D to revenue (%): 697.4768280123584
SG&A to revenue (%): 2307.7239958805353
Free cash flow (dilution-adjusted): -208736000
Buyback yield (%): 0
Retained earnings: -732871000
Receivables turnover: 0.2317975650513249
Capitalized R&D asset: 24845840
ROCI (R&D-adjusted, %): -6.248186427761009
Rosenberg metric: -0.2505880224353175
FCF margin (%): -10748.506694129763
Revenue growth (%): -76.43775782577045
Rule of 40 score: -10824.944451955533
Financial ratios for SMR — annual report dated 2025-12-31
Total revenue: 31479000
Gross profit: 11431000
Operating income: -689571000
Net income: -355794000
Capital expenditures: 508000
Operating cash flow: -459610000
Depreciation & amortization: 1181000
Net tangible assets: 1143159000
Owner earnings: -355121000
Return on net tangible assets (%): -31.064882487912882
Buffett classification: The Gruesome
Stock price: 14.17
Shares outstanding: 346105785
Book value: 1113551000
P/B ratio: 4.404215858501317
Market cap (USD): 4904318973.45
Debt to equity: 0
Current ratio: 4.298416515794309
Quick ratio: 4.298416515794309
COGS to revenue (%): 63.68690237936402
R&D to revenue (%): 144.64246005273358
SG&A to revenue (%): 1937.2438768702946
Free cash flow (dilution-adjusted): -479278000
Buyback yield (%): 0
Retained earnings: -732871000
Receivables turnover: 3.757340654094056
Capitalized R&D asset: 128395890
ROCI (R&D-adjusted, %): -58.38756180598052
Rosenberg metric: -0.4416558087874063
FCF margin (%): -1522.5324819721084
Revenue growth (%): -15.024969631529222
Rule of 40 score: -1537.5574516036377
Financial ratios for SOFTX.OL — annual report dated 2021-12-31
Capital expenditures: 522251.70454545453
Buffett classification: The Gruesome
Stock price: 6.385404789053592
Shares outstanding: 2659955723
Market cap (USD): 16984894012.314709
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SOFTX.OL — annual report dated 2022-12-31
Total revenue: 0
Operating income: -9216089.777327934
Net income: -7200518.724696356
Capital expenditures: 491343.92712550604
Operating cash flow: -8697980.465587044
Depreciation & amortization: 394750.5060728745
Net tangible assets: 3118796.4574898784
Owner earnings: -7297112.145748988
Return on net tangible assets (%): -233.97205445147807
Buffett classification: The Gruesome
Stock price: 2.3582995951417005
Shares outstanding: 2659955723
Book value: 3921173.4817813765
P/B ratio: 1599.7691848604356
Market cap (USD): 6272972504.645749
Debt to equity: 1.2878008612744356
Current ratio: 0.7078487065772131
Quick ratio: 0.7078487065772131
Interest coverage ratio: -40.68997450144653
Free cash flow (dilution-adjusted): -9189324.39271255
Buyback yield (%): 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -114.09554733366171
Rule of 40 score: 0
Financial ratios for SOFTX.OL — annual report dated 2023-12-31
Total revenue: 0
Operating income: -3205765.618860511
Net income: -3875122.1021611
Capital expenditures: 747470.8251473478
Operating cash flow: 74329.76424361493
Depreciation & amortization: 734646.2671905698
Net tangible assets: -877690.7662082515
Owner earnings: -3887946.6601178776
Buffett classification: The Gruesome
Stock price: 0.31827111984282913
Shares outstanding: 2659955723
Book value: 232450.58939096145
P/B ratio: 3642.0087766164665
Market cap (USD): 846587086.6915522
Debt to equity: 31.271524843989656
Current ratio: 0.17453327041221803
Quick ratio: 0.17453327041221803
Interest coverage ratio: -3.6529490158380638
Free cash flow (dilution-adjusted): -673141.0609037328
Buyback yield (%): 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -68.05241037704414
Rule of 40 score: 0
Financial ratios for SOFTX.OL — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.0019083969465648854
Shares outstanding: 2659955723
Market cap (USD): 5076251.379770992
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SOFTX.OL — quarterly report dated 2024-12-31
Total revenue: 142894.96910856134
Operating income: -77052.07413945279
Net income: -315622.24183583405
Capital expenditures: 0
Operating cash flow: 1114386.584289497
Depreciation & amortization: 129479.25860547219
Net tangible assets: 6069902.912621359
Owner earnings: -186142.98323036186
Return on net tangible assets (%): -3.0666550340254752
Buffett classification: The Gruesome
Stock price: 0.0008818342151675486
Shares outstanding: 2659955723
Book value: 8401147.39629303
P/B ratio: 0.27920471534723196
Market cap (USD): 2345639.9673721343
Debt to equity: 0.1065609077060461
Current ratio: 0.40553243951302204
Quick ratio: 0.40553243951302204
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 1114386.584289497
Buyback yield (%): 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.9171613174344695
FCF margin (%): 779.8641136504015
Rule of 40 score: 779.8641136504015
Financial ratios for SOFTX.OL — annual report dated 2024-12-31
Total revenue: 0
Operating income: -2865225.06619594
Net income: -3790291.2621359224
Capital expenditures: 1750660.635481024
Operating cash flow: 2873874.6690203003
Depreciation & amortization: 474139.4527802295
Net tangible assets: 6069902.912621359
Owner earnings: -5066812.444836717
Return on net tangible assets (%): -83.4743572965742
Buffett classification: The Gruesome
Stock price: 0.0008818342151675486
Shares outstanding: 2659955723
Book value: 8401147.39629303
P/B ratio: 0.27920471534723196
Market cap (USD): 2345639.9673721343
Debt to equity: 0.1065609077060461
Current ratio: 0.40553243951302204
Quick ratio: 0.40553243951302204
Interest coverage ratio: -3.5401308615049074
Free cash flow (dilution-adjusted): 2873874.6690203003
Buyback yield (%): 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -34.105163628723005
Rule of 40 score: 0
Financial ratios for SOFTX.OL — quarterly report dated 2025-03-31
Total revenue: 306870.2290076336
Operating income: 122709.92366412214
Net income: 186354.96183206106
Capital expenditures: 0
Operating cash flow: -440458.01526717556
Depreciation & amortization: 74332.06106870229
Net tangible assets: 8481106.870229008
Owner earnings: 260687.02290076335
Return on net tangible assets (%): 3.07373821471164
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.003816793893129771
P/E ratio: 13.619844971838198
Shares outstanding: 2659955723
Book value: 9895038.16793893
P/B ratio: 1.0260195652844744
Market cap (USD): 10152502.759541985
Debt to equity: 0
Current ratio: 1.2579809229751338
Quick ratio: 1.2579809229751338
Effective tax rate (%): 0
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): -440458.01526717556
Buyback yield (%): 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.240115718418515
FCF margin (%): -143.5323383084577
Revenue growth (%): 114.75229738458854
Rule of 40 score: -28.78004092386915
Financial ratios for SOFTX.OL — quarterly report dated 2025-06-30
Total revenue: 426117.17974180734
Operating income: -325819.26514399203
Net income: -331976.16683217476
Capital expenditures: 0
Operating cash flow: -633465.7398212512
Depreciation & amortization: 77358.49056603774
Net tangible assets: 8963455.809334656
Owner earnings: -254617.67626613702
Return on net tangible assets (%): -2.8406195298132104
Buffett classification: The Gruesome
Stock price: 0.012909632571996028
Shares outstanding: 2659955723
Book value: 10357596.82224429
P/B ratio: 3.315349267888131
Market cap (USD): 34339051.041708045
Debt to equity: 0
Current ratio: 1.4418112877351612
Quick ratio: 1.4418112877351612
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): -633465.7398212512
Buyback yield (%): 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.1457033010230004
FCF margin (%): -148.6599860172454
Revenue growth (%): 38.859080960638714
Rule of 40 score: -109.80090505660667
Financial ratios for SOFTX.OL — quarterly report dated 2025-09-30
Total revenue: 447194.3887775551
Operating income: -551703.4068136272
Net income: -555811.6232464929
Capital expenditures: 0
Operating cash flow: 28757.51503006012
Depreciation & amortization: 78056.1122244489
Net tangible assets: 8717434.869739478
Owner earnings: -477755.51102204405
Return on net tangible assets (%): -5.480459770114942
Buffett classification: The Gruesome
Stock price: 0.008016032064128256
Shares outstanding: 2659955723
Book value: 10046192.384769538
P/B ratio: 2.1224250490220524
Market cap (USD): 21322290.364729457
Debt to equity: 0
Current ratio: 1.16209014019233
Quick ratio: 1.16209014019233
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 28757.51503006012
Buyback yield (%): 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.491666749783066
FCF margin (%): 6.430652027784002
Revenue growth (%): 4.946341062455833
Rule of 40 score: 11.376993090239836
Financial ratios for SP3.AX — annual report dated 2021-06-30
Total revenue: 3946527.819548872
Gross profit: 2360903.0075187967
Operating income: -1845609.0225563908
Net income: -1319860.902255639
Capital expenditures: 211637.59398496238
Depreciation & amortization: 238494.73684210525
Net tangible assets: 1696115.037593985
Owner earnings: -1293003.7593984962
Return on net tangible assets (%): -76.23325840166359
Buffett classification: The Gruesome
Stock price: 0.052631578947368425
Shares outstanding: 415922712
Book value: 1831144.3609022554
P/B ratio: 11.95463859651428
Market cap (USD): 21890669.05263158
Debt to equity: 0.15942863290222395
Current ratio: 1.7441821515337654
Quick ratio: 1.3816526371486166
Interest coverage ratio: -554.7254237288136
COGS to revenue (%): 40.17771784543832
R&D to revenue (%): 3.476492708351988
SG&A to revenue (%): 95.01507178100023
Free cash flow (dilution-adjusted): -936302.2556390977
Buyback yield (%): 0.16827645613159012
Retained earnings: -7756033.082706766
Inventory turnover: 2.721442278036373
Receivables turnover: 4.254675060023961
Capitalized R&D asset: 137200.75187969924
ROCI (R&D-adjusted, %): -81.72586544555904
FCF margin (%): -23.72470937620621
Rule of 40 score: -23.72470937620621
Financial ratios for SP3.AX — annual report dated 2022-06-30
Total revenue: 4019326.896551724
Gross profit: 2209006.896551724
Operating income: -1483013.103448276
Net income: -1316399.3103448276
Capital expenditures: 131535.8620689655
Depreciation & amortization: 221315.86206896554
Net tangible assets: 377414.4827586207
Owner earnings: -1226619.3103448276
Return on net tangible assets (%): -325.00589309110444
Buffett classification: The Gruesome
Stock price: 0.027586206896551727
Shares outstanding: 415922712
Book value: 443698.6206896552
P/B ratio: 25.859287027696652
Market cap (USD): 11473729.986206898
Debt to equity: 1.6301186111106793
Current ratio: 1.264892507747463
Quick ratio: 0.9491776143890138
Interest coverage ratio: -29.700819049460645
COGS to revenue (%): 45.04037732171316
R&D to revenue (%): 2.8066287990577936
SG&A to revenue (%): 82.78558907787614
Free cash flow (dilution-adjusted): -1114924.8275862068
Buyback yield (%): 0.04665530263228327
Retained earnings: -8405640.689655174
Inventory turnover: 4.041732810852008
Receivables turnover: 4.682715964074685
Capitalized R&D asset: 204732.08996629505
ROCI (R&D-adjusted, %): -114.08289755033832
Rosenberg metric: -1.1071084442763015
FCF margin (%): -27.739093044229058
Revenue growth (%): 1.844636103722535
Rule of 40 score: -25.894456940506522
Financial ratios for SP3.AX — annual report dated 2023-06-30
Total revenue: 4879190.728476821
Gross profit: 2747660.264900662
Operating income: -1847991.390728477
Net income: -1935804.6357615893
Capital expenditures: 106552.3178807947
Depreciation & amortization: 207869.53642384105
Net tangible assets: 986851.655629139
Owner earnings: -1834487.417218543
Return on net tangible assets (%): -185.89292592806342
Buffett classification: The Gruesome
Stock price: 0.013245033112582781
Shares outstanding: 415922712
Book value: 1144538.4105960266
P/B ratio: 4.813215565082195
Market cap (USD): 5508910.092715232
Debt to equity: 0.895383951308055
Current ratio: 1.611320283760857
Quick ratio: 1.1697041665791394
Interest coverage ratio: -27.21424461413929
COGS to revenue (%): 43.686147605088124
R&D to revenue (%): 3.874421146270864
SG&A to revenue (%): 85.40520371823685
Free cash flow (dilution-adjusted): -952588.0794701987
Buyback yield (%): 3.8626767753909044
Retained earnings: -10007446.357615894
Inventory turnover: 3.0019763767483334
Receivables turnover: 6.090039883449402
Capitalized R&D asset: 309897.72822991485
ROCI (R&D-adjusted, %): -75.03687664413128
Rosenberg metric: 4.774974684424256
FCF margin (%): -19.523485194184577
Revenue growth (%): 21.393229614212146
Rule of 40 score: 1.869744420027569
Financial ratios for SP3.AX — annual report dated 2024-06-30
Total revenue: 5457248.666666667
Gross profit: 2681876.6666666665
Operating income: -1881461.3333333333
Net income: -1718818
Capital expenditures: 142012
Depreciation & amortization: 159135.33333333334
Net tangible assets: -49276
Owner earnings: -1701694.6666666667
Buffett classification: The Gruesome
Stock price: 0.013333333333333334
Shares outstanding: 415922712
Book value: 52816.66666666651
P/B ratio: 104.99784461975419
Market cap (USD): 5545636.16
Debt to equity: 10.554925844114894
Current ratio: 1.0305463952880367
Quick ratio: 0.8196333545877619
Interest coverage ratio: -46.35663600525624
COGS to revenue (%): 50.85661602617094
R&D to revenue (%): 0.8185443385207661
SG&A to revenue (%): 79.05687029349221
Free cash flow (dilution-adjusted): -270304.6666666667
Buyback yield (%): 0.30191907384947037
Retained earnings: -11621135.333333334
Inventory turnover: 6.434441634878731
Receivables turnover: 5.093390436273766
Capitalized R&D asset: 208553.5696734414
ROCI (R&D-adjusted, %): -161.81947484705813
Rosenberg metric: -0.3479869866748871
FCF margin (%): -4.953130838946561
Revenue growth (%): 11.847414261059289
Rule of 40 score: 6.894283422112728
Financial ratios for SUNDRMFAST.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 11.50876961624687
Shares outstanding: 210128370
Market cap (USD): 2418319000.16748
Buyback yield (%): 0
Retained earnings: 27457470.658050902
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SUNDRMFAST.NS — annual report dated 2023-03-31
Total revenue: 668708891.5956151
Gross profit: 295045066.99147385
Operating income: 80113276.49208283
Net income: 60943970.76735689
Capital expenditures: 27818514.007308163
Operating cash flow: 57120584.65286237
Depreciation & amortization: 24113276.492082827
Net tangible assets: 366484774.66504264
Owner earnings: 57238733.252131544
Return on net tangible assets (%): 15.618311375812604
Capex to operating income (%): 34.72397488331078
Buffett classification: The Good
Stock price: 11.62448233861145
P/E ratio: 40.07998650482662
Shares outstanding: 210128370
Book value: 369557856.27283806
P/B ratio: 6.609610604794879
Market cap (USD): 2442633525.9062123
Debt to equity: 0.240696490193041
Current ratio: 1.7668065246087121
Quick ratio: 1.0412580929033879
Effective tax rate (%): 24.265128810583356
Interest coverage ratio: 19.528800475059384
COGS to revenue (%): 55.87839930055919
SG&A to revenue (%): 3.1247153968051586
Free cash flow (dilution-adjusted): 28066991.473812427
Buyback yield (%): 0
Retained earnings: 50042630.937880635
Inventory turnover: 3.3221935847176796
Receivables turnover: 4.796648523026114
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 19.623948658429978
FCF margin (%): 4.197191307990747
Rule of 40 score: 4.197191307990747
Financial ratios for SUNDRMFAST.NS — annual report dated 2024-03-31
Total revenue: 658733661.1104449
Gross profit: 305541431.8263581
Operating income: 81044489.74697205
Net income: 63033936.92289244
Capital expenditures: 47723947.715553425
Operating cash flow: 70598393.09269696
Depreciation & amortization: 25582204.101211175
Net tangible assets: 409426789.7829476
Owner earnings: 40892193.30855019
Return on net tangible assets (%): 9.987669182622042
Capex to operating income (%): 58.88611041238182
Buffett classification: The Good
Stock price: 12.866242802303264
P/E ratio: 42.89058815062442
Shares outstanding: 210128370
Book value: 412678978.2947595
P/B ratio: 6.551248719388789
Market cap (USD): 2703562628.072217
Debt to equity: 0.18787503668639743
Current ratio: 1.8640874330571169
Quick ratio: 1.125264068724129
Effective tax rate (%): 24.427063864048076
Interest coverage ratio: 21.640409862311877
COGS to revenue (%): 53.61684852853903
SG&A to revenue (%): 2.710815957241525
Free cash flow (dilution-adjusted): 22686173.402086582
Buyback yield (%): 0
Retained earnings: 73189830.91497782
Inventory turnover: 3.1075788429682305
Receivables turnover: 4.404233313289237
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 18.2374815150632
FCF margin (%): 3.443906808078381
Revenue growth (%): -1.4917149465992916
Rule of 40 score: 1.9521918614790892
Financial ratios for SUNDRMFAST.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 433748208.3134257
Buffett classification: The Gruesome
Stock price: 16.131032011466793
Shares outstanding: 210128370
Book value: 437299331.10367894
P/B ratio: 7.751183735937853
Market cap (USD): 3389587462.9873385
Debt to equity: 0.22806174151272715
Current ratio: 1.8071434920244225
Quick ratio: 1.112950314168701
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SUNDRMFAST.NS — quarterly report dated 2024-12-31
Total revenue: 167982282.31728637
Gross profit: 102636670.94066907
Operating income: 19976687.259587362
Net income: 15238372.770719197
Capital expenditures: 0
Depreciation & amortization: 6557873.8780743675
Owner earnings: 21796246.648793563
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 12.181839375218555
P/E ratio: 41.99513442201484
Shares outstanding: 210128370
Market cap (USD): 2559750051.5164933
Effective tax rate (%): 21.218512715439317
Interest coverage ratio: 20.5
COGS to revenue (%): 38.900299766848015
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SUNDRMFAST.NS — quarterly report dated 2025-03-31
Total revenue: 178932663.08159924
Gross profit: 107776478.84030862
Operating income: 19475099.36871639
Net income: 14553425.298106149
Capital expenditures: 0
Depreciation & amortization: 6794482.113631049
Net tangible assets: 444677343.932663
Owner earnings: 21347907.411737196
Return on net tangible assets (%): 4.800763453100477
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 10.514412416851442
P/E ratio: 37.95285813141636
Shares outstanding: 210128370
Book value: 448038344.63408923
P/B ratio: 4.9312215553004535
Market cap (USD): 2209376342.660754
Debt to equity: 0.21486645862252515
Current ratio: 1.936968649438613
Quick ratio: 1.1850399786405856
Effective tax rate (%): 24.207001522070012
Interest coverage ratio: 17.480587618048272
COGS to revenue (%): 39.767017947327496
Buyback yield (%): 0
Retained earnings: 116608604.16179565
Inventory turnover: 0.5687494743923975
Receivables turnover: 1.0512582763262728
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.058716043367037
Revenue growth (%): 6.518771273526151
Rule of 40 score: 6.518771273526151
Financial ratios for SUNDRMFAST.NS — annual report dated 2025-03-31
Total revenue: 675215104.0448912
Gross profit: 322493570.2595277
Operating income: 84320785.59738134
Net income: 63332943.65209258
Capital expenditures: 46039279.8690671
Operating cash flow: 49482113.6310498
Depreciation & amortization: 26176057.984568622
Net tangible assets: 444677343.932663
Owner earnings: 43469721.7675941
Return on net tangible assets (%): 9.77556476863743
Capex to operating income (%): 54.600155279503106
Buffett classification: The Good
Stock price: 10.514412416851442
P/E ratio: 34.88510426418107
Shares outstanding: 210128370
Book value: 448038344.63408923
P/B ratio: 4.9312215553004535
Market cap (USD): 2209376342.660754
Debt to equity: 0.21486645862252515
Current ratio: 1.936968649438613
Quick ratio: 1.1850399786405856
Effective tax rate (%): 24.230769230769226
Interest coverage ratio: 21.82390317700454
COGS to revenue (%): 52.23839509400445
SG&A to revenue (%): 2.9372605305940835
Free cash flow (dilution-adjusted): 3220715.4547580075
Buyback yield (%): 0
Retained earnings: 116608604.16179565
Inventory turnover: 2.819293770265093
Receivables turnover: 3.966997719717575
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 17.57290778413936
FCF margin (%): 0.4769910263357912
Revenue growth (%): 2.501988877669182
Rule of 40 score: 2.9789799040049734
Financial ratios for SUNDRMFAST.NS — quarterly report dated 2025-06-30
Total revenue: 179427802.48069274
Gross profit: 108458928.15352212
Operating income: 22048911.77158905
Net income: 17358998.361806694
Capital expenditures: 0
Depreciation & amortization: 6861689.679382168
Owner earnings: 24220688.041188862
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 12.041422887900772
P/E ratio: 53.6628170774965
Shares outstanding: 210128370
Market cap (USD): 2530244563.915282
Effective tax rate (%): 25.706824687390146
Interest coverage ratio: 20.706593406593406
COGS to revenue (%): 39.55288608899236
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 0.27671828640235946
Rule of 40 score: 0.27671828640235946
Financial ratios for SUNDRMFAST.NS — quarterly report dated 2025-12-31
Total revenue: 171673164.7543723
Gross profit: 104162860.64386767
Operating income: 20358694.441350117
Net income: 14570569.232483013
Capital expenditures: 0
Depreciation & amortization: 6404143.923359698
Owner earnings: 20974713.15584271
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 10.360699565556423
P/E ratio: 35.2726626894957
Shares outstanding: 210128370
Market cap (USD): 2177076911.7700796
Effective tax rate (%): 24.974188367557648
Interest coverage ratio: 23.673575129533678
COGS to revenue (%): 39.324902180895585
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -4.321870757545994
Rule of 40 score: -4.321870757545994
Financial ratios for TCMD — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 2300000
Buffett classification: The Gruesome
Stock price: 19.03
Shares outstanding: 22556260
Market cap (USD): 429245627.8
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TCMD — annual report dated 2022-12-31
Total revenue: 246785000
Gross profit: 175976000
Operating income: -12758000
Net income: -17866000
Capital expenditures: 1769000
Operating cash flow: 5209000
Depreciation & amortization: 14432000
Net tangible assets: 39962000
Owner earnings: -5203000
Return on net tangible assets (%): -13.019868875431658
Buffett classification: The Gruesome
Stock price: 11.48
Shares outstanding: 22556260
Book value: 121400000
P/B ratio: 2.1329972388797365
Market cap (USD): 258945864.8
Debt to equity: 0.5949670510708402
Current ratio: 1.8616974972796518
Quick ratio: 1.5022384579511892
Interest coverage ratio: -4.576040172166428
COGS to revenue (%): 32.00072937982454
R&D to revenue (%): 2.8721356646473652
SG&A to revenue (%): 67.75695443402152
Free cash flow (dilution-adjusted): -6311000
Buyback yield (%): 0
Retained earnings: -9621000
Inventory turnover: 3.415196332814392
Receivables turnover: 4.501240287454857
Capitalized R&D asset: 7088000
ROCI (R&D-adjusted, %): -4.0619490208373366
FCF margin (%): -2.5572867070526977
Rule of 40 score: -2.5572867070526977
Financial ratios for TCMD — annual report dated 2023-12-31
Total revenue: 274423000
Gross profit: 195133000
Operating income: 18041000
Net income: 28515000
Capital expenditures: 2324000
Operating cash flow: 35855000
Depreciation & amortization: 6539000
Net tangible assets: 115855000
Owner earnings: 32730000
Return on net tangible assets (%): 28.25083077985413
Capex to operating income (%): 12.881769303253702
Buffett classification: The Great
Stock price: 14.3
P/E ratio: 11.311748833947046
Shares outstanding: 22556260
Book value: 193642000
P/B ratio: 1.6657260201815722
Market cap (USD): 322554518
Debt to equity: 0.26014500986356265
Current ratio: 3.538836252039847
Quick ratio: 2.9901600214336166
Effective tax rate (%): -80.81800887761572
Interest coverage ratio: 4.350373764166868
COGS to revenue (%): 28.89335077599181
R&D to revenue (%): 2.850708577633799
SG&A to revenue (%): 61.65408876078171
Free cash flow (dilution-adjusted): 25827000
Buyback yield (%): 0
Retained earnings: 18894000
Inventory turnover: 3.5197762684778264
Receivables turnover: 6.356356982373242
Capitalized R&D asset: 12571960
ROCI (R&D-adjusted, %): 8.259902025525484
Rosenberg metric: 2.702737020316027
FCF margin (%): 9.41138315665961
Revenue growth (%): 11.19922199485382
Rule of 40 score: 20.610605151513433
Financial ratios for TCMD — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 14.61
Shares outstanding: 22556260
Market cap (USD): 329546958.59999996
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TCMD — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 17.13
Shares outstanding: 22556260
Market cap (USD): 386388733.79999995
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TCMD — annual report dated 2024-12-31
Total revenue: 292984000
Gross profit: 216688000
Operating income: 22181000
Net income: 16960000
Capital expenditures: 2380000
Operating cash flow: 40655000
Depreciation & amortization: 6792000
Net tangible assets: 142745000
Owner earnings: 21372000
Return on net tangible assets (%): 14.972153140215068
Capex to operating income (%): 10.729903971867815
Buffett classification: The Great
Stock price: 17.13
P/E ratio: 22.782354587264148
Shares outstanding: 22556260
Book value: 216597000
P/B ratio: 1.7839062119973959
Market cap (USD): 386388733.79999995
Debt to equity: 0.20827158270890178
Current ratio: 4.3622985455974845
Quick ratio: 3.903719536163522
Effective tax rate (%): 27.795989612158884
Interest coverage ratio: 10.638369304556354
COGS to revenue (%): 26.041012478497123
R&D to revenue (%): 3.0144990852742812
SG&A to revenue (%): 62.509898151434896
Free cash flow (dilution-adjusted): 30327000
Buyback yield (%): 0.9078939661361317
Retained earnings: 35854000
Inventory turnover: 4.087431693989071
Receivables turnover: 6.5198833923047825
Capitalized R&D asset: 16412450
ROCI (R&D-adjusted, %): 8.441493933437599
Rosenberg metric: 2.7553368273041032
FCF margin (%): 10.35107719192857
Revenue growth (%): 6.7636459043156005
Rule of 40 score: 17.11472309624417
Financial ratios for TCMD — quarterly report dated 2025-03-31
Total revenue: 61268000
Gross profit: 45346000
Operating income: -4542000
Net income: -2974000
Capital expenditures: 379000
Operating cash flow: 417000
Depreciation & amortization: 1726000
Net tangible assets: 132702000
Owner earnings: -1627000
Return on net tangible assets (%): -1.2260553721873069
Buffett classification: The Gruesome
Stock price: 13.22
Shares outstanding: 22556260
Book value: 205631000
P/B ratio: 1.4501400917176888
Market cap (USD): 298193757.2
Debt to equity: 0.2122539889413561
Current ratio: 4.523092568006554
Quick ratio: 3.9901415214259486
Interest coverage ratio: -10.712264150943396
COGS to revenue (%): 25.987464908271857
R&D to revenue (%): 2.8416138930599986
SG&A to revenue (%): 77.55108702748579
Free cash flow (dilution-adjusted): -2056000
Buyback yield (%): 3.3595606071930204
Retained earnings: 32880000
Inventory turnover: 0.8439073514602216
Receivables turnover: 1.6610095971371253
Capitalized R&D asset: 1741000
ROCI (R&D-adjusted, %): -1.3712814939181828
FCF margin (%): -3.3557485147222037
Rule of 40 score: -3.3557485147222037
Financial ratios for TCMD — quarterly report dated 2025-06-30
Total revenue: 78905000
Gross profit: 58793000
Operating income: 4083000
Net income: 3217000
Capital expenditures: 369000
Operating cash flow: 14757000
Depreciation & amortization: 1659000
Net tangible assets: 122959000
Owner earnings: 4507000
Return on net tangible assets (%): 3.665449458762677
Capex to operating income (%): 9.037472446730344
Buffett classification: The Great
Stock price: 10.14
P/E ratio: 941.2365283950618
Shares outstanding: 22556260
Book value: 194926000
P/B ratio: 1.1733707991750717
Market cap (USD): 228720476.4
Debt to equity: 0.2163590285544258
Current ratio: 3.786525753038141
Quick ratio: 3.363017597703141
Effective tax rate (%): 28.890362511052164
Interest coverage ratio: 9.958536585365854
COGS to revenue (%): 25.488879031747036
R&D to revenue (%): 2.557505861478994
SG&A to revenue (%): 65.99455040871935
Free cash flow (dilution-adjusted): 12421000
Buyback yield (%): 7.233283289890874
Retained earnings: 36097000
Inventory turnover: 1.1753842557419203
Receivables turnover: 2.3523536952568347
Capitalized R&D asset: 3184470
ROCI (R&D-adjusted, %): 2.0557227220160397
Rosenberg metric: 7.723721998851235
FCF margin (%): 15.74171472023319
Revenue growth (%): 28.786642292877197
Rule of 40 score: 44.52835701311039
Financial ratios for TCMD — quarterly report dated 2025-09-30
Total revenue: 85755000
Gross profit: 65001000
Operating income: 10963000
Net income: 8209000
Capital expenditures: 1122000
Operating cash flow: 10341000
Depreciation & amortization: 1638000
Net tangible assets: 133863000
Owner earnings: 8725000
Return on net tangible assets (%): 6.517857809850369
Capex to operating income (%): 10.234424883699718
Buffett classification: The Great
Stock price: 13.84
P/E ratio: 36.93547543776621
Shares outstanding: 22556260
Book value: 204949000
P/B ratio: 1.523201569170867
Market cap (USD): 312178638.4
Debt to equity: 0.08163494332736437
Current ratio: 3.608406063389986
Quick ratio: 3.1979533506864697
Effective tax rate (%): 28.22418466381044
Interest coverage ratio: 56.803108808290155
COGS to revenue (%): 24.201504285464402
R&D to revenue (%): 2.554953063961285
SG&A to revenue (%): 59.76444522185296
Free cash flow (dilution-adjusted): 7373000
Buyback yield (%): 0
Retained earnings: 44306000
Inventory turnover: 1.2903506590400398
Receivables turnover: 2.3017151139383203
Capitalized R&D asset: 4117590
ROCI (R&D-adjusted, %): 4.984488397640923
Rosenberg metric: 3.076313181367691
FCF margin (%): 8.59774940236721
Revenue growth (%): 8.68132564476269
Rule of 40 score: 17.2790750471299
Financial ratios for TCMD — quarterly report dated 2025-12-31
Total revenue: 103594000
Gross profit: 81006000
Operating income: 18775000
Net income: 10634000
Capital expenditures: 510000
Operating cash flow: 17296000
Depreciation & amortization: 1620000
Net tangible assets: 148672000
Owner earnings: 11744000
Return on net tangible assets (%): 7.8992681876883335
Capex to operating income (%): 2.7163781624500665
Buffett classification: The Great
Stock price: 29
P/E ratio: 34.27284606517866
Shares outstanding: 22556260
Book value: 218902000
P/B ratio: 2.9882392120675005
Market cap (USD): 654131540
Debt to equity: 0.0729002019168395
Current ratio: 4.032692824181459
Quick ratio: 3.690260517127719
Effective tax rate (%): 45.32366702658234
Interest coverage ratio: 1706.8181818181818
COGS to revenue (%): 21.804351603374712
R&D to revenue (%): 2.4431916906384537
SG&A to revenue (%): 57.05349730679383
Free cash flow (dilution-adjusted): 14181000
Buyback yield (%): 0.0001528744509093691
Retained earnings: 54940000
Inventory turnover: 1.6105525846702318
Receivables turnover: 2.3610629957151974
Capitalized R&D asset: 4664910
ROCI (R&D-adjusted, %): 8.019920282458063
Rosenberg metric: 7.3048836147877685
FCF margin (%): 13.689016738421145
Revenue growth (%): 20.802285581015685
Rule of 40 score: 34.49130231943683
Financial ratios for TCMD — annual report dated 2025-12-31
Total revenue: 329522000
Gross profit: 250146000
Operating income: 29279000
Net income: 19086000
Capital expenditures: 2380000
Operating cash flow: 42811000
Depreciation & amortization: 6643000
Net tangible assets: 148672000
Owner earnings: 23349000
Return on net tangible assets (%): 15.705041971588463
Capex to operating income (%): 8.128692919840159
Buffett classification: The Great
Stock price: 29
P/E ratio: 34.27284606517866
Shares outstanding: 22556260
Book value: 218902000
P/B ratio: 2.9882392120675005
Market cap (USD): 654131540
Debt to equity: 0.0729002019168395
Current ratio: 4.032692824181459
Quick ratio: 3.690260517127719
Effective tax rate (%): 39.09824818915728
Interest coverage ratio: 28.20712909441233
COGS to revenue (%): 24.088224761927883
R&D to revenue (%): 2.5737280060208425
SG&A to revenue (%): 63.71107240184267
Free cash flow (dilution-adjusted): 31919000
Buyback yield (%): 4.060498290603752
Retained earnings: 54940000
Inventory turnover: 5.6596078431372545
Receivables turnover: 7.510301759504057
Capitalized R&D asset: 16980030
ROCI (R&D-adjusted, %): 11.754177507683107
Rosenberg metric: 3.788269927536232
FCF margin (%): 9.686454925619534
Revenue growth (%): 12.470988176828769
Rule of 40 score: 22.157443102448305
Financial ratios for TECHNOE.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.1735460899380192
Shares outstanding: 116299574
Market cap (USD): 369082058.32915735
Buyback yield (%): 0
Retained earnings: 69972306.47500989
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TECHNOE.NS — annual report dated 2023-03-31
Total revenue: 100774092.57003655
Gross profit: 24550426.309378807
Operating income: 9824116.930572473
Net income: 22760000
Capital expenditures: 7933617.539585872
Operating cash flow: 11371291.108404385
Depreciation & amortization: 2990742.99634592
Net tangible assets: 235100584.65286237
Owner earnings: 17817125.45676005
Return on net tangible assets (%): 7.578511760431356
Capex to operating income (%): 80.75654632017458
Buffett classification: The Gruesome
Stock price: 4.0221680876979296
P/E ratio: 20.552567449721607
Shares outstanding: 116299574
Book value: 235103800.24360538
P/B ratio: 1.9896591831819483
Market cap (USD): 467776435.15566385
Debt to equity: 0
Current ratio: 4.435771810738188
Quick ratio: 4.261537124602048
Effective tax rate (%): 32.46809986033422
Interest coverage ratio: 15.358074528247997
COGS to revenue (%): 75.63815690792094
SG&A to revenue (%): 1.7726241676339054
Free cash flow (dilution-adjusted): 3388051.157125457
Buyback yield (%): 1.8320014623894332
Retained earnings: 84644238.73325214
Inventory turnover: 6.192869746098756
Receivables turnover: 1.2900975531106378
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.6847544882019188
FCF margin (%): 3.3620259639359293
Rule of 40 score: 3.3620259639359293
Financial ratios for TECHNOE.NS — annual report dated 2024-03-31
Total revenue: 179588367.90982133
Gross profit: 40439021.46540353
Operating income: 24242762.921213575
Net income: 32192984.770356156
Capital expenditures: 21636059.479553904
Operating cash flow: -23772598.63292961
Depreciation & amortization: 940520.4460966543
Net tangible assets: 259408442.2592637
Owner earnings: 11497445.736898907
Return on net tangible assets (%): 4.432178705043021
Capex to operating income (%): 89.24749852097642
Buffett classification: The Gruesome
Stock price: 9.16098848368522
P/E ratio: 33.09475855288053
Shares outstanding: 116299574
Book value: 259411344.28588557
P/B ratio: 4.107064249654967
Market cap (USD): 1065419058.071497
Debt to equity: 0
Current ratio: 4.299591989186678
Quick ratio: 4.253873945155607
Effective tax rate (%): 15.63437742023045
Interest coverage ratio: 19.226271541065927
COGS to revenue (%): 77.48238266427722
SG&A to revenue (%): 1.4647425585979152
Free cash flow (dilution-adjusted): -45409425.59059839
Buyback yield (%): 0
Retained earnings: 111837966.18299556
Inventory turnover: 44.88619141010317
Receivables turnover: 2.0208608135247683
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.912714864625185
FCF margin (%): -25.285282181193562
Revenue growth (%): 78.2088663165188
Rule of 40 score: 52.92358413532523
Financial ratios for TECHNOE.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 418319111.32345915
Buffett classification: The Gruesome
Stock price: 18.99916387959866
Shares outstanding: 116299574
Book value: 418321906.3545151
P/B ratio: 5.2820438805347845
Market cap (USD): 2209594665.5535116
Debt to equity: 0
Current ratio: 5.642314093377132
Quick ratio: 5.642314093377132
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0